- Home
- IMNM vs FBK Comparison
IMNM vs FBK Comparison
Compare IMNM & FBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IMNM | FBK |
|---|---|---|
| Founded | 2006 | 1906 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 3.0B |
| IPO Year | 2020 | 2016 |
Fundamental Metrics
Financial Performance| Metric | IMNM | FBK |
|---|---|---|
| Price | $21.92 | $58.02 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 4 |
| Target Price | $32.10 | ★ $61.75 |
| AVG Volume (30 Days) | ★ 1.0M | 216.3K |
| Earning Date | 01-01-0001 | 04-22-2026 |
| Dividend Yield | N/A | ★ 1.44% |
| EPS Growth | ★ 7.06 | N/A |
| EPS | N/A | ★ 1.34 |
| Revenue | ★ $9,041,000.00 | N/A |
| Revenue This Year | N/A | $43.98 |
| Revenue Next Year | $11.53 | $7.90 |
| P/E Ratio | ★ N/A | $43.42 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.15 | $38.83 |
| 52 Week High | $27.65 | $62.37 |
Technical Indicators
Market Signals| Indicator | IMNM | FBK |
|---|---|---|
| Relative Strength Index (RSI) | 43.67 | 47.25 |
| Support Level | $18.98 | $55.80 |
| Resistance Level | $22.57 | $60.20 |
| Average True Range (ATR) | 1.18 | 1.69 |
| MACD | -0.31 | -0.30 |
| Stochastic Oscillator | 15.51 | 34.45 |
Price Performance
Historical ComparisonAbout IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About FBK FB Financial Corporation
FB Financial Corp is a bank holding company. The company through its wholly-owned bank subsidiary provides commercial and consumer banking services to clients in select markets in Tennessee, North Alabama, and North Georgia. The company segment includes Banking and Mortgage. It generates revenue from the Banking segment which provides a full range of deposit and lending products and services to corporate, commercial, and consumer customers. The Mortgage segment includes the servicing of residential mortgage loans and the packaging and securitization of loans to governmental agencies.